Ann: Investor Update Presentation, page-20

I find this statement interesting and revealing;

• "Isolating PhytoTech at MMJ should have a positive impact on valuation as MMJ becomes a pure play biotech company with 53.3M HVST shares "
  
  Sort of sums up to me how MMJ sees the HVST transaction.
  
  Overall I think the Investors Update Presentation goes a long way to clearing the air.
  
  @serge83 , I agree that when the License to sell is acquired, there will be a significant rerate of HVST. At that point, MMJ will also be rerated. From my analysis, apart from the first week or so after HVST listed, the two companies SP's have been locked at the hip, with MMJ following HVST.  
  
  Cheers
  
  Dr D.